The Role of the Vascular Surgeon in Orthopedic Surgery of Musculoskeletal Tumors
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 7, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the role of vascular surgeons during orthopedic surgery for patients with muscle cancer, particularly when large tumors are close to blood vessels. Sometimes, these tumors can be complicated to remove because they involve important blood vessels, and having a vascular surgeon present during surgery can help ensure that the procedure goes smoothly. The goal is to make surgeries safer and reduce complications that can happen during and after the operation.
To be eligible for this trial, patients need to be at least 18 years old and have a diagnosed musculoskeletal tumor that requires surgical removal and involves vascular structures. Participants will receive surgical treatment with the help of a vascular surgeon, and they will be asked to provide informed consent before joining the study. This trial is currently recruiting participants of all genders, so if you or someone you know may fit this description, it could be a good opportunity to receive specialized surgical care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient diagnosed with musculoskeletal tumor involving vascular structures requiring surgical removal
- • Planned surgical treatment with intraoperative assistance of the vascular surgeon
- • Obtaining informed consent
- • Age 18 years
- Exclusion Criteria:
- • -
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Mauro Gargiulo, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported